Assistant Professor Department of Pharmaceutical Sciences and Natural Products School of Health Sciences
|
Exam |
Year of Passing |
Roll No./ Regn. No. |
Institute/Department
|
Board/ University |
Subjects |
|
Ph. D. |
2013 |
10/Ph.D./Pharm. Sci.-6 |
Department of Pharmaceutical Sciences
|
M.D.U., Rohtak, Haryana |
Pharmaceutical Sciences |
|
Pre Ph. D. |
2012 |
1111610009 |
|||
|
M. Pharm. (Pharm. Chem.) |
2008 |
0613308 |
Department of Pharmaceutical Sciences |
G.J.U.S.&T., Hisar, Haryana |
Pharmaceutical Chemistry |
|
B. Pharm. |
2006 |
0213124 |
Pharmaceutical Sciences |
||
|
10+2 |
2001 |
2215467 |
Yaduvanshi Shiksha Niketan, Mahendergarh, Haryana |
C.B.S.E., New Delhi |
Physics, Chemistry, Biology, English, Hindi, Physical and Health Education |
|
Matriculation |
1999 |
348420 |
Arya Vart High School, Adampur Dadhi, Bhiwani, Haryana |
B.S.E.H., Bhiwani, Haryana |
English, Hindi, Mathematics, Science, Social Science, Physical and Health Education |
|
GATE |
2006 |
PY 819137 |
IIT Kharagpur |
-- |
Pharm. Sciences |
|
Period |
Position held |
Pay Scale |
Institute/Organization |
|
July 31, 2024 – Till date |
Assistant Professor
|
Pay matrix Academic Level -12 (7th CPC) |
Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda |
|
July 31, 2019 – July 30, 2024 |
Pay matrix Academic Level -11 |
||
|
January 01, 2016 – July 30, 2019 |
Pay matrix Academic Level -10 |
||
|
July 31, 2015 – December 31, 2015 |
PB-3, Rs. 15600-39100 with AGP 6000 (6th CPC) |
||
|
June 18, 2013 – July 30, 2015 |
Doon Valley Institute of Pharmacy and Medicine, Karnal, Haryana |
||
|
July 18, 2009 – October 28, 2009 |
Lecturer |
8000-275-13500 |
Rayat & Bahra Institute of Pharmacy, Mohali |
|
Aug 5, 2008 – July 17, 2009 |
Lecturer |
8000-275-13500 |
P.D.M. School of Pharmacy, Safidon, Jind, Haryana |
Design and synthesis of novel medicinally potent compounds.
Biological screening of novel/synthesized medicinal compounds for their antibacterial, antifungal, antimycobacterial, antiviral and anticancer compounds.
QSAR studies/molecular docking to correlate the physicochemical parameters/molecular descriptors of the novel/synthesized compounds and their biological property of interest.
Organic synthesis
Molecular modeling
Antimicrobial/anticancer evaluation
|
S. No. |
Title |
Funding agency |
Cost (Rs.) |
|
1 |
Design, synthesis, and biological evaluation of novel pyrido[2,3-d]pyrimidine derivatives as thymidylate synthase inhibitors |
ANRF |
36.33 Lakhs |
|
2 |
Design, synthesis, and anticancer evaluation of novel benzimidazole conjugated pyrido[2,3-d]pyrimidine/ alkylated substituted benzimidazole conjugated pyrido[2,3-d]pyrimidine derivatives as anti-colorectal cancer agents targeting thymidylate synthase |
ICMR |
44.54 Lakhs |
|
3 |
Synthesis of novel quinoline derivatives as anti-methicillin resistant Staphylococcus aureus (MRSA) agents |
CUPB |
3.00 Lakhs |
|
4 |
Synthesis of pyridine based anti-Methicillin resistant Staphylococcus aureus agents |
UGC |
10.00 Lakhs |
Registered as Pharmacist with Haryana State Pharmacy Council.
Life member of Association of Pharmaceutical Teachers of India.
Awarded with UGC- Dr. D.S. Kothari Post Doctoral Fellowship - 2015.
Awarded with UGC-JRF/SRF (October 29, 2009 to June 18, 2013).
Qualified GATE in Pharmaceutical Sciences in 2006 (GATE score 421, AIR = 709).
Secured a position in two disciplines: Medicinal and Biomolecular Chemistry as well as microbiology in the Stanford/Elsevier Top 2% Scientists List, 2024.
·Awarded with CUPB Research Award (2022-2023) for research publication(s) with cumulative impact factor of 24 or more as Corresponding/ First author.
Awarded with CUPB Research Award (2022-2023) for research publication(s) with cumulative impact factor of 36 or more.
Awarded with CUPB Research Award (2021-2022) for research publication(s) with cumulative impact factor more than 30.
(Total PUBLICATIONS = 107, Total JIF = 331.20, TotAL CITATIONS = 2942, Google scholar h Index = 27; i10 Index = 55); IF 0-1 = 14; 1-2 = 18; 2-5 = 54; 5-10 = 20; >10 = 01; API (Publications) = 1352.40; Total API = 1653.6
https://scholar.google.com/citations?user=_mtcJwYAAAAJ&hl=en&authuser=1
https://www.scopus.com/authid/detail.uri?authorId=57214055090
https://www.webofscience.com/wos/author/record/AAM-5133-2021
RESEARCH ARTICLES (International)
|
S. No. |
Publication Details |
ISSN NO. |
Journal Impact factor |
API Score |
|
1 |
Kumar P, Narasimhan B, Sharma D, Synthesis, antimicrobial evaluation and QSAR analysis of substituted benzoic acid benzylidene/furan-2-yl-methylene hydrazides, ARKIVOC, xiii, 2008, 159-178. |
1551-7012 |
0.80 |
12.6 |
|
2 |
Kumar P, Narasimhan B, Sharma D, Judge V, Narang R, Hansch analysis of substituted benzoic acid benzylidene/furan-2-yl-methylene hydrazides as antimicrobial agents, European Journal of Medicinal Chemistry, 2009, 44(5), 1853-1863. Doi: 10.1016/j.ejmech.2008.10.034 |
0223-5234 |
6.00 |
23.1 |
|
3 |
Sharma D, Narasimhan B, Kumar P, Narang R, Judge V, Clerq E D, Balzarini J, Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives, European Journal of Medicinal Chemistry, 2009, 44(6), 2347-2353. Doi: 10.1016/j.ejmech.2008.08.010 |
0223-5234 |
6.00 |
9.9 |
|
4 |
Sharma D, Narasimhan B, Kumar P, Jalbout A, Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones, European Journal of Medicinal Chemistry, 2009, 44(3), 1119-1127. Doi: 10.1016/j.ejmech.2008.06.009 |
0223-5234 |
6.00 |
9.9 |
|
5 |
Sharma D, Narasimhan B, Kumar P, Narang R, Judge V, Clerq ED, Balzarini J, Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles, Journal of Enzyme Inhibition and Medicinal Chemistry, 2009, 24(5), 1161-1168. Doi: 10.1080/14756360802694427 |
1475-6374 |
5.60 |
9.9 |
|
6 |
Kumar P, Narasimhan B, Yogeswari P and Sriram D, Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides, European Journal of Medicinal Chemistry, 2010, 45, 6085-6089. Doi: 10.1016/j.ejmech.2010.08.030 |
0223-5234 |
6.00 |
23.1 |
|
7 |
Yadav S, Kumar P, Clercq E D, Balzarini J, Pannecouque C and Narasimhan B, 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulphonic acids: Synthesis, antimicrobial activity, QSAR studies and antiviral evaluation, European Journal of Medicinal Chemistry 2010, 45, 5985-5997. Doi: 10.1016/j.ejmech.2010.09.065 |
0223-5234 |
6.00 |
9.9 |
|
8 |
Judge V, Narang R, Sharma D, Narasimhan B, Kumar P, Hansch analysis for the prediction of antimycobacterial activity of ofloxacin derivatives, Medicinal Chemistry Research, 2011, 20(7), 826-837. Doi: 10.1007/s00044-010-9400-8 |
1554-8120 |
2.60 |
8.4 |
|
9 |
Narasimhan B, Sharma D, Kumar P, Yogeswari P, Sriram D, Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-benzimidazol-1-yl / imidazol-1-yl]-pyridin-3-yl-methanones, Journal of Enzyme Inhibition and Medicinal Chemistry, 2011, 26(5), 720-727. Doi: 10.3109/14756366.2010.548331 |
1475-6374 |
5.60 |
9.9 |
|
10 |
Narasimhan B, Saharan R, Kumar P, Hansch analysis of anti-inflammatory and analgesic activities of substituted 1-alkyl/aryl-3-ethoxy carbonyl-5-hydroxy-2-methyl indoles, Acta Pharmaceutica Sciencia, 2011, 53, 117 – 126. |
1307-2080 |
-- |
3.9 |
|
11 |
Kumar D, Kapoor A, Thangadurai A, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of 3-ethoxy-4-hydroxybenzylidene/4-nitrobenzylidene hydrazides, Chinese Chemical Letters, 2011, 22, 1293-1296. Doi: 10.1016/j.cclet.2011.06.014 |
1001-8417 |
9.40 |
9.9 |
|
12 |
Mahiwal K, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation, ot-QSAR and mt-QSAR studies of 2-amino benzoic acid derivatives, Medicinal Chemistry Research, 21(3), 2012, 293-307. Doi: 10.1007/s00044-011-9550-3 |
1554-8120 |
2.60 |
8.4 |
|
13 |
Singh M, Kumar S, Kumar A, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR analysis of 2-isopropyl-5-methylcyclohexanol derivatives, Medicinal Chemistry Research, 2012, 21(4), 511-522. Doi: 10.1007/s00044-011-9550-3 |
1554-8120 |
2.60 |
8.4 |
|
14 |
Sharma D, Narasimhan B, Kumar P, Synthesis and antibacterial evaluation of Cu(II) and Zn(II) complexes of the β-lactum antibiotic, cefdinir, Medicinal Chemistry Research, 2012, 21, 796-803. Doi: 10.1007/s00044-011-9588-2 |
1554-8120 |
2.60 |
8.4 |
|
15 |
Kumar R, Kumar P, Kumar M, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of 4-amino-3-hydroxy-naphthalene-1-sulfonic acid derivatives, Medicinal Chemistry Research, 2012, 21, 4301–4310. Doi: 10.1007/s00044-011-9954-0 |
1554-8120 |
2.60 |
8.4 |
|
16 |
Sharma SK, Narasimhan B, Kumar P, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters, European Journal of Medicinal Chemistry, 2012, 48, 16-25. doi: 10.1016/j.ejmech.2011.11.028 |
0223-5234 |
6.00 |
9.9 |
|
17 |
Sigroha S, Narasimhan B, Kumar P, Khatkar A, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Design, synthesis, antimicrobial, anticancer evaluation, and QSAR studies of 4-(substituted benzylidene-amino)-1,5-dimethyl-2-phenyl-1,2-dihydropyrazol-3-ones, Medicinal Chemistry Research, 2012, 21, 3863–3875. Doi: 10.1007/s00044-011-9906-8 |
1554-8120 |
2.60 |
8.4 |
|
18 |
Kumar H, Narasimhan B, Kumar P, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, in vitro antimicrobial, anti-proliferative and QSAR studies of N-(substituted phenyl)-2/4-(1H-indol-3-ylazo)-benzamides, Medicinal Chemistry Research, 2013, 22, 1957-1971. Doi: 10.1007/s00044-012-0181-0 |
1554-8120 |
2.60 |
8.4 |
|
19 |
Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Clercq ED, N'-(4-((substituted imino)methyl)benzylidene)-substituted benzohydrazides:synthesis, antimicrobial, antiviral, anticancer evaluation, and QSAR studies, Monatshefte für Chemie 2013, 144, 825–849. Doi: 10.1007/s00706-012-0877-3 |
1434-4475 |
1.70 |
16.1 |
|
20 |
Sapra A, Kumar P, Kakkar S, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of p-hydroxy benzoic acid derivatives, Drug Research, 2014, 64(01), 17-22. DOI: 10.1055/s-0033-1349866 |
0004-4172 |
1.70 |
6.9 |
|
21 |
Kumar M, Narasimhan B, Kumar P, Ramasamy K, Mani V, Mishra RK, Majeed ABA, 4-(1-Aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides: Synthesis, antimicrobial, anticancer evaluation and QSAR studies, Arabian Journal of Chemistry 2014, 7, 436–447. Doi: 10.1016/j.arabjc.2013.03.002 |
1878-5352 |
5.30 |
9.9 |
|
22 |
Saini M, Kumar P, Kumar M, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Narasimhan B, Synthesis, in vitro antimicrobial, anticancer evaluation and QSAR studies of N’-(substituted)-4-(butan-2-lideneamino)benzohydrazides, Arabian Journal of Chemistry, 2014, 7, 448–460. Doi: 10.1016/j.arabjc.2013.05.010 |
1878-5352 |
5.30 |
9.9 |
|
23 |
Tahlan S, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of stearic acid derivatives, Drug Research, 2014, 64(02), 98-103. DOI: 10.1055/s-0033-1353173 |
0004-4172 |
1.70 |
6.9 |
|
24 |
Mehta S, Kumar P, Marwaha RK, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of 2-chlorobenzoic acid derivatives, Drug Research, 2014, 64(04), 208-213. DOI: 10.1055/s-0033-1355355 |
0004-4172 |
1.70 |
6.9 |
|
25 |
Bansal A, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of 2-hydroxy propanoic acid derivatives, Drug Research 2014, 64, 240-245. DOI: 10.1055/s-0033-1357127 |
0004-4172 |
1.70 |
6.9 |
|
26 |
Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 3/4-Bromo benzohydrazide derivatives, Current Topics in Medicinal Chemistry, 2015, 15, 1052-1066. Doi: 10.2174/156802661511150408111252 |
1873-5294 |
2.90 |
19.6 |
|
27 |
Khatkar A, Nanda A, Kumar P, Narasimhan B, Synthesis and antimicrobial evaluation of ferulic acid derivatives, Research on Chemical Intermediates, 2015, 41, 299-309. Doi: 10.1007/s11164-013-1192-2 |
1568-5675 |
2.80 |
8.4 |
|
28 |
Deep A, Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, antimicrobial, anticancer evaluation of 2-(aryl)-4-thiazolidinone derivatives and their QSAR studies, Current Topics in Medicinal Chemistry, 2015, 15 (11), 990-1002. DOI: 10.2174/1568026615666150317221849 |
1873-5294 |
2.90 |
8.4 |
|
29 |
Devi J, Kumari S, Devi S, Malhotra R, Kumar P, Narasimhan B, Synthesis, biological evaluation, and QSAR studies of organosilicon(IV) complexes derived from tridentate ONO Schiff bases of dehydroacetic acid and aromatic hydrazides, Monatshefte für Chemie, 2015, 146, 1995-2005. Doi: 10.1007/s00706-015-1470-3 |
1434-4475 |
1.70 |
6.9 |
|
30 |
Vashist N, Sambi SS, Kumar P, Narasimhan B, Development of QSAR for antimicrobial activity of substituted benzimidazoles, Drug Research 2015; 65(05), 225-230. Doi: 10.1055/s-0034-1371828 |
0004-4172 |
1.70 |
6.9 |
|
31 |
Devi J, Kumari S, Batra N, Kumar P, Narasimhan B, Malhotra R, Synthesis, antimicrobial activities and QSAR studies of heterocyclic Schiff base ligands with organosilicon (IV) halides, Medicinal Chemistry Research, 2016, 25, 235-246. Doi: 10.1007/s00044-015-1478-6 |
1554-8120 |
2.60 |
8.4 |
|
32 |
Deep A, Kumar P, Narasimhan B, Lim SM, Ramasamy K, Mishra RK, Mani V, 2-Azetidinone derivatives: Synthesis, antimicrobial, anticancer evaluation and QSAR studies, Acta Poloniae Pharmaceutica - Drug Research, 2016, 73(1), 65-78. |
00016837 |
0.40 |
5.4 |
|
33 |
Deep A, Kumar P, Narasimhan B, Meng LS, Ramasamy K, Mishra RK, Mani V, Synthesis, antimicrobial and anticancer evaluation of 2-azetidinones clubbed with quinazolinone, Pharmaceutical Chemistry Journal, 2016, 50(1),24-28. Doi: 10.1007/s11094-016-1392-3 |
1573-9031 |
0.80 |
5.4 |
|
34 |
Deep A, Kumar P, Narasimhan B, Ramasamy K, Lim SM, Mani V, Mishra RK, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of thiazolidin-4-one derivatives, Acta Poloniae Pharmaceutica - Drug Research, 2016, 73(1), 93-106. |
00016837 |
0.40 |
5.4 |
|
35 |
Selvam C, Thilagavathi R, Narasimhan B, Kumar P, Jordan BC, Ranganna K, Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives, Bioorganic & Medicinal Chemistry Letters 2016, 26(04), 1140-1144. Doi: 10.1016/j.bmcl.2016.01.051 |
0960-894X |
2.50 |
8.4 |
|
36 |
Kaushik CP, Kumar K, Narasimhan B, Singh D, Kumar P, Pahwa A, Synthesis, antimicrobial activity, and QSAR studies of amide-ester linked 1,4-disubstituted 1,2,3-triazoles, Monatshefte für Chemie, 2017, 148:765–779. Doi: 10.1007/s00706-016-1766-y |
1434-4475 |
1.70 |
6.9 |
|
37 |
Khatkar A, Nanda A, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of gallic acid derivatives, Arabian Journal of Chemistry, 2017, 10, S2870–S2880. Doi: 10.1016/j.arabjc.2013.11.014 |
1878-5352 |
5.30 |
9.9 |
|
38 |
Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 2/3-bromo-N'-(substitutedbenzylidene/3-phenylallylidene) benzohydrazides, Arabian Journal of Chemistry 2017, 10 S3740–S3748. Doi: 10.1016/j.arabjc.2014.05.010 |
1878-5352 |
5.30 |
23.1 |
|
39 |
Khatkar A, Nanda A, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of p- coumaric acid derivatives, Arabian Journal of Chemistry, 2017, 10, S3804–S3815. Doi: 10.1016/j.arabjc.2014.05.018 |
1878-5352 |
5.30 |
9.9 |
|
40 |
Kumar S, Kumar P, Marwaha RK, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives, Arabian Journal of Chemistry 2017, 10, S881–S893. Doi: 10.1016/j.arabjc.2012.12.024 |
1878-5352 |
5.30 |
9.9 |
|
41 |
Tahlan S, Kumar P, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Narasimhan B, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of N'-substituted benzylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxopentylidene-4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino) benzohydrazides, Arabian Journal of Chemistry, 2017, 10, S2009–S2017. Doi: 10.1016/j.arabjc.2013.07.029 |
1878-5352 |
5.30 |
9.9 |
|
42 |
Gupta R, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of monochloroacetic acid derivatives, Arabian Journal of Chemistry, 2017, 10, S909-S920. doi: 10.1016/j.arabjc.2012.12.027 |
1878-5352 |
5.30 |
9.9 |
|
43 |
Arora S, Joshi G, Kalra S, Wani A, Prasad B, Kumar P, Kumar R, Knoevenagel/Tandem Knoevenagel and Michael Adducts of cyclohexane-1,3-dione and aryl aldehydes: Synthesis, DFT studies, xanthine oxidase inhibitory potential and molecular modeling, ACS Omega, 2019, 4(3), 4604-4614. Doi: 10.1021/acsomega.8b03060 |
2470-1343
|
3.70 |
8.4 |
|
44 |
Verma D, Kumar P, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed ABA, Synthesis, antimicrobial, anticancer and QSAR studies of 1-[4-(substituted phenyl)-2-(substituted phenyl azomethyl)-benzo[b]-[1,4]diazepin-1-yl]-2-substituted phenylaminoethanones, Arabian Journal of Chemistry, 2019, 12, 2882-2896 doi: 10.1016/j.arabjc.2015.06.010 |
1878-5352 |
5.30 |
9.9 |
|
45 |
Verma S, Pathania AS, Baranwal S, Kumar P, Synthesis and in silico studies of quinazolinone derivatives as PARP-1 inhibitors, Letters in Drug Design & Discovery, 2020, 17(12), 1552 – 1565. Doi: 10.2174/1570180817999200719152959 |
1875-628X |
1.20 |
16.1 |
|
46 |
Bhardwaj N, Choudhary D, Pathania A, Baranwal S, Kumar P, Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors, Turkish Journal of Chemistry, 2020, 44(6), 1623-1641. Doi: 10.3906/kim-2004-14 |
13036130 |
1.30 |
16.1 |
|
47 |
Singh AK, Novak J, Kumar A, Singh H, Thareja S, Pathak P, Grishina M, Verma A, Yadav JP, Khalilullah H, Pathania V, Nandanwar H, Jaremko M, Emwas A-H, Kumar P, Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAFV600E inhibitors, RSC Advances, 2022, 12, 30181–30200. Doi: 10.1039/D2RA05751D |
2046-2069 |
3.90 |
19.6 |
|
48 |
Bisht G, Singh AK, Kumar A, Kumar P, A mechanistic study of the antibacterial activity of phytoconstituents of Pyracantha crenulata by using molecular docking studies, Current Chinese Chemistry, 2022, 2, 20-39. DOI: 10.2174/2666001602666220722112558 |
2666-0008 |
-- |
9.1 |
|
49 |
Kumar H, Kumar D, Kumar P, Thareja S, Marwaha MG, Navik U, Marwaha RK, Synthesis, biological evaluation and ADME studies of novel series of thiazolidine-2,4-dione derivatives as antimicrobial, antioxidant and anticancer agents, BMC Chemistry, 2022, 16(1): 68. Doi: 10.1186/s13065-022-00861-7 |
2661-801X |
4.30 |
8.4 |
|
50 |
Pauly I, Singh AK, Kumar A, Singh Y, Thareja S, Kamal MA, Verma A, Kumar P, Current insights and molecular docking studies of the drugs under clinical trial as rdrp inhibitors in COVID-19 treatment, Current Pharmaceutical Design, 2022, 28(46), 3677-3705. Doi: 10.2174/1381612829666221107123841 |
1873-4286 |
2.60 |
19.6 |
|
51 |
Bihari A, Yadav A, Jangid K, Singh Y, Kulkarni S, Sawant D, Kumar P, Thareja S, Jain A, Flavonoids as promising anticancer agents: An in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations, Journal of Biomolecular Structure & Dynamics, 2023, 41(16), 7835-7846. Doi: 10.1080/07391102.2022.2126397 |
1538-0254 |
2.70 |
8.4 |
|
52 |
Banjare L, Singh Y, Verma S, Singh A, Kumar P, Kumar S, Jain A, Thareja S, Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors, Journal of Biomolecular Structure & Dynamics, 2023, 41 (04), 1322-1341. Doi: 10.1080/07391102.2021.2019122 |
1538-0254 |
2.70 |
8.4 |
|
53 |
Singh Y, Sanjay KS, Kumar P, Singh S, Thareja S, Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors, Journal of Biomolecular Structure & Dynamics, 2023, 41(8):3524-3541. Doi: 10.1080/07391102.2022.2051745 |
1538-0254 |
2.70 |
8.4 |
|
54 |
Bora P, Kumar A, Singh AK, Singh H, Narasimhan B, Kumar P, Molecular docking and QSAR studies of indole derivatives as antifungal agents, Current Chinese Chemistry, 2023, 3, e280323215084, doi: 10.2174/2666001603666230328181833. |
2666-0008 |
-- |
9.1 |
|
55 |
Kumar A, Novak J, Singh AK, Singh H, Thareja S, Pathak P, Grishina M, Kumar P, Virtual screening, structure based pharmacophore mapping, and molecular simulation studies of pyrido[2,3-d]pyrimidines as selective thymidylate synthase inhibitors, Journal of Biomolecular Structure & Dynamics, 2023, 41(23), 14197-14211. Doi: 10.1080/07391102.2023.2208205 |
1538-0254 |
2.70 |
19.6 |
|
56 |
Kumar R, Kumar A, Kumar A, Singh AK, Kumar P, Design, synthesis and molecular docking studies of pyrazoline derivatives as PI3K inhibitors, Combinatorial Chemistry and High Throughput Screening, 2024, 27(2) 256 – 272. doi: 10.2174/1386207326666230504163312. |
1875-5402 |
1.60 |
16.1 |
|
57 |
Shah M, Kumar A, Singh AK, Singh H, Narasimhan B, Kumar P, In silico studies of indole derivatives as antibacterial agents, Journal of Pharmacopuncture, 2023, 26(2), 147-157. doi: 10.3831/KPI.2023.26.2.147 |
20936966 |
1.20 |
16.1 |
|
58 |
Rathi J, Faujdar S, Dhiman A, Yadav R, Kumar P, Molecular docking based antidiabetic screening of Curcuma caesia RoxB., European Chemical Bulletin, 2023, 12(5), 914 – 929. Doi: 10.31838/ecb/2023.12.si5.0112 |
2063-5346 |
-- |
3.9 |
|
59 |
Guleria M, Kumar A, Singh AK, Kumar P, Synthesis and in silico studies of quinazolinones as PARP-1 inhibitors, Combinatorial Chemistry and High Throughput Screening, 2024, 27(9), 1329-1343 doi: 10.2174/1386207326666230905153443. |
1875-5402 |
1.60 |
16.1 |
|
60 |
Sharma A, Kumar A, Singh AK, Singh H, Kumar JK, Kumar P, Phytochemical profiling and pharmacological evaluation of leaf extracts of Ruellia tuberosa L: An in vitro and in silico approach, Chemistry & Biodiversity, 2023, doi: 10.1002/cbdv.202300495. |
1612-1880 |
2.30 |
19.6 |
|
61 |
Singh AK, Sreelakshmi P, Pathak P, Kumar A, Singh H, Yadav JP, Verma A, Grishina M, Kumar P, Design, virtual screening, molecular docking, ADME and cytotoxicity studies of 1,3,5-triazine containing heterocyclic scaffolds as selective BRAF monomeric, homo and heterodimeric inhibitors, Combinatorial Chemistry and High Throughput Screening, 2024, doi: 10.2174/0113862073273813231113071010. |
1875-5402 |
1.60 |
16.1 |
|
62 |
Ram T, Singh AK, Pathak P, Kumar A, Singh H, Grishina M, Novak J, Kumar P, Design, one-pot synthesis, computational, and biological evaluation of diarylbenzimidazole derivatives as MEK inhibitors, Journal of Biomolecular Structure & Dynamics, 2023, doi: 10.1080/07391102.2023.2265486 |
1538-0254 |
2.70 |
19.6 |
|
63 |
Bajpai P, Singh AK, Kandagalla S, Chandra P, Sah KV, Kumar P, Grishina M, Verma OP, Pathak P, Oxazoline/amide derivatives against M. Tuberculosis: Experimental, biological and computational investigations, Journal of Biomolecular Structure & Dynamics, 2023, doi: 10.1080/07391102.2023.2276312 |
1538-0254 |
2.70 |
8.4 |
|
64 |
Agrawal S, Kumar A, Singh AK, Singh H, Kumar P, Antioxidant and antibacterial evaluation of leaf extracts of Prunus cerasoides Buch.-Ham. ex D. Don; An in vitro and in silico study, Pharmacological Research – Natural Products, 2024, 3, 100037. doi: 10.1016/j.prenap.2024.100037. |
2950-1997 |
-- |
9.1 |
|
65 |
Kumar A, Singh AK, Singh H, Narasimhan B, Kumar P, Synthesis and anticancer evaluation of new benzylated indole based alkyl-substituted pyrido[2,3-d]pyrimidines targeting thymidylate synthase,ChemistrySelect, 2024, doi: 10.1002/slct.202400249. |
2365-6549 |
1.90 |
16.1 |
|
66 |
Kumar A, Backer N, Paliwal H, Singh AK, Debbaraman T, Singh V, Kumar P, Synthesis and anticancer evaluation of diaryl pyrido[2,3-d]pyrimidine /alkyl substituted pyrido[2,3-d]pyrimidine derivatives as thymidylate synthase inhibitors, BMC Chemistry, 2024, 18(1), 161. Doi: 10.1186/s13065-024-01228-w. |
2661-801X |
4.30 |
19.6 |
|
67 |
Arora S, Upadhayay S, Kumar P, Kumar P, Kumar R, Design, synthesis and anticancer evaluation of 4-Substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as dual topoisomerase I and II inhibitors, Bioorganic Chemistry, 2024, in press
|
0045-2068
|
4.30 |
8.4 |
REVIEW ARTICLES
|
S. No. |
Publication Details |
ISSN No. |
Journal Impact factor |
API |
|
1 |
Narasimhan B, Kumar P, Sharma D, Biological activities of hydrazide derivatives in the new millennium, Acta Pharmaceutica Sciencia, 2010, 52, 169-180. |
1307-2080 |
-- |
3.9 |
|
2 |
Narasimhan B, Sharma D, Kumar P, Biological importance of imidazole nucleus in the new millennium, Medicinal Chemistry Research, 2011, 20(8), 1119-1140. DOI: 10.1007/s00044-010-9472-5 |
1554-8120 |
2.60 |
8.4 |
|
3 |
Narasimhan B, Sharma D, Kumar P, Benzimidazole: A medicinally important heterocyclic moiety, Medicinal Chemistry Research, 2012, 21(3), 269-283. DOI: 10.1007/s00044-010-9533-9 |
1554-8120 |
2.60 |
8.4 |
|
|
4 |
Kumar P, Narasimhan B, Hydrazides/hydrazones as antimicrobial and anticancer agents in the new millennium, Mini Reviews in Medicinal Chemistry, 2013, 13(7), 971-987. DOI: 10.2174/1389557511313070003 |
1875-5607 |
3.30 |
19.6 |
|
|
5 |
Kumar P, A review on quinoline derivatives as anti-methicillin resistant Staphylococcus aureus (MRSA) agents, BMC Chemistry, 2020, 14(1), 17. Doi: 10.1186/s13065-020-00669-3 |
2661-801X |
4.30 |
28.0 |
|
|
6 |
Bhardwaj N, Pathania, Kumar P, Naturally available nitrogen-containing fused heterocyclics as prospective lead molecules in medicinal chemistry, Current Traditional Medicine, 2021, 7(1), 5-27. DOI: 10.2174/2215083805666190613125700 |
2215-0846 |
0.60 |
12.6 |
|
|
7 |
Adak M, Kumar P, Herbal anthelmintic agents: A narrative review, Journal of Traditional Chinese Medicines, 2022, 42(4), 641-651. Doi: 10.19852/j.cnki.jtcm.2022.04.007 |
2552922 |
2.00 |
19.6 |
|
|
8 |
Angre T, Kumar A, Singh AK, Thareja S, Kumar P, Role of collagen regulators in cancer treatment: A comprehensive review, Anti-Cancer Agents in Medicinal Chemistry, 2022, 22(17), 2956-2984. Doi: 10.2174/1871520622666220501162351 |
1875-5992 |
2.60 |
19.6 |
|
|
9 |
Yadav M, Singh AK, Kumar A, Thareja S, Kumar P, An insight to Heat shock protein 90: A remedy for multiple problems, Current Pharmaceutical Design, 2022, 28(32), 2664-2676. Doi: 10.2174/1381612828666220829120630 |
1873-4286 |
2.60 |
19.6 |
|
|
10 |
Das S, Kulkarni S, Singh Y, Kumar P, Thareja S, Selective estrogen receptor modulators (SERMs) for the treatment of ER+ breast cancer: An overview, Journal of Molecular Structure, 2022, 1270, 133853. Doi.: 10.1016/j.molstruc.2022.133853 |
0022-2860 |
4.00 |
8.4 |
|
|
11 |
Guleria M, Thareja S, Kumar P, Synthetic PARP-1 inhibitors reported during last decade, Letters in Drug Design and Discovery, 2023, 20(7), 793-807. DOI: 10.2174/1570180819666220615090709 |
1875-628X |
1.20 |
16.1 |
|
|
12 |
Singh AK, Kumar A, Thareja S, Kumar P, Current insights into the role of BRAF inhibitors in treatment of melanoma, Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(3), 278 – 297. Doi: 10.2174/1871520622666220624164152 |
1875-5992 |
2.60 |
19.6 |
|
|
13 |
Kumar A, Singh AK, Thareja S, Kumar P, A review of pyridine and pyrimidine derivatives as anti-MRSA agents, Anti-Infective Agents, 2023, 21(2), 18-40. DOI: 10.2174/2211352520666220705085733 |
2211-3533 |
-- |
9.1 |
|
|
14 |
Bisht G, Singh AK, Kumar A, Kumar P, A review of phytoconstituents as antibacterial agents, The Natural Products Journal, 2023, 13(5), 39-56. DOI: 10.2174/2210315512666220804111049 |
2210-3163 |
0.70 |
12.6 |
|
|
15 |
Singh AK, Kumar A, Singh H, Sonawane P, Paliwal H, Thareja S, Pathak P, Grishina M, Jaremko M, Emwas A.-H, Yadav JP, Verma A, Khalilullah H, Kumar P, Concept of hybrid drugs and recent advancements in anticancer hybrids, Pharmaceuticals, 2022, 15(9), 1071. Doi: 10.3390/ph15091071 |
1424-8247 |
4.30 |
19.6 |
|
|
16 |
Bhatia N, Khator R, Kulkarni S, Singh Y, Kumar P, Thareja S, Recent advancements in the discovery of MDM2/MDM2-p53 interaction inhibitors for the treatment of cancer, Current Medicinal Chemistry, 2023, 30(32):3668-3701. Doi: 10.2174/0929867330666221114103924 |
1875-533X |
3.50 |
8.4 |
|
|
17 |
Sahu R, Singh AK, Kumar A, Singh K, Kumar P, Bacteriophages concept and applications: A review on phage therapy, Current Pharmaceutical Biotechnology, 2023, 24(10):1245-1264. Doi: 10.2174/1389201024666221104142457 |
1873-4316 |
2.80 |
19.6 |
|
|
18 |
Kumar A, Singh AK, Singh H, Thareja S, Kumar P, Regulation of thymidylate synthase: An approach to overcome 5-FU resistance in colorectal cancer, Medical Oncology, 2022, 40(1), 3. Doi: 10.1007/s12032-022-01864-z. |
13570560 |
3.40 |
19.6 |
|
|
19 |
Lohit N, Singh AK, Kumar A, Singh H, Yadav J, Singh K, Kumar P. Lipinski’s rule of 5: Description and in silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the Rule of 5, Letters in Drug Design & Discovery, 2023, doi: 10.2174/1570180820666230224112505. |
1875-628X |
1.20 |
16.1 |
|
|
20 |
Raj A, Kumar A, Singh AK, Singh H, Thareja S, Kumar P, Synthetic methodologies and SAR of quinazoline derivatives as PI3K inhibitors, Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(9):1013-1047. Doi: 10.2174/1871520623666230116163424 |
1875-5992 |
2.60 |
19.6 |
|
|
21 |
Kumar A, Singh AK, Singh H, Vijayan V; Kumar D; Naik J, Thareja S, Yadav JP, Pathak P, Grishina M, Verma A, Khalilullah H, Jaremko M, Emwas A.-H, Kumar P. Nitrogen containing heterocycles as anticancer agents: A medicinal chemistry perspective, Pharmaceuticals, 2023, 16(2), 299. Doi: 10.3390/ph16020299 |
1424-8247 |
4.30 |
19.6 |
|
|
22 |
Kumar A, Bhagat KK, Singh AK, Singh H, Angre T, Verma A, Khalilullah H, Jaremko M, Emwas A-H, Kumar P, Medicinal chemistry perspective of pyrido[2, 3-d]pyrimidines as anticancer agents, RSC Advances, 2023, 13, 6872 – 6908. DOI: 10.1039/D3RA00056G |
2046-2069 |
3.90 |
19.6 |
|
|
23 |
Singh AK, Kumar A, Singh H, Sonawane P, Pathak P, Grishina M, Yadav JP, Verma A, Kumar P, Metal complexes in cancer treatment: Journey so far, Chemistry & Biodiversity, 2023, 20(4), e202300061. doi: 10.1002/cbdv.202300061. |
1612-1880 |
2.30 |
19.6 |
|
|
24 |
Singh AK, Sonawane P, Kumar A, Singh H, Naumovich V, Pathak P, Grishina M, Khalilullah H, Jaremko M, Emwas A-H, Verma A, Kumar P., Challenges and opportunities in the crusade of BRAF inhibitors: From 2002-2022, ACS Omega, 2023, 8(31), 27819–27844. doi: 10.1021/acsomega.3c00332 |
2470-1343
|
3.70 |
19.6 |
|
|
25 |
Agarwal S, Kumar A, Singh AK, Singh H, Thareja S, Kumar P, A comprehensive review on pharmacognosy, phytochemistry and pharmacological activities of 8 potent Prunus species of Southeast Asia, Journal of Traditional Chinese Medicines, 2024, 44(3), 620-628. doi: 10.19852/j.cnki.jtcm.2024.03.002. |
2552922 |
2.00 |
19.6 |
|
|
26 |
Thakral S, Yadav A, Singh V, Kumar M, Kumar P, Narang R, Kalvatala Sudhakar K, Verma A, Khalilullah H, Jaremko M, Emwas A-H, Alzheimer’s disease: Molecular aspects and treatment opportunities using herbal drugs, Ageing Research Reviews, 2023, doi: 10.1016/j.arr.2023.101960. |
1568-1637 |
12.50 |
11.4 |
|
|
27 |
Ram T, Singh AK, Kumar A, Singh H, Pathak P, Grishina M, Khalilullah H, Jaremko M, Emwas A.-H, Verma A, Kumar P, MEK inhibitors in cancer treatment: Structural insights, regulation, recent advances and future perspectives, RSC Medicinal Chemistry, 2023, 14, 1837 – 1857. Doi: 10.1039/D3MD00145H |
2632-8682 |
4.10 |
19.6 |
|
|
28 |
Singh H, Kumari AVS, Singh AK, Kumar A, Kumar P, Medicinal chemistry aspects of isoxazole analogues as anti-tubercular agents, Current Organic Chemistry, 2023, 27(15), 1308 – 1318. Doi: 10.2174/0113852728264519231006055100 |
1385-2728 |
1.70 |
16.1 |
|
|
29 |
Singh AK, Kumar A, Arora S, Kumar R, Verma A, Khalilullah H, Jaremko M, Emwas A-H, Kumar P, Current insights and molecular docking studies of HIV-1 reverse transcriptase inhibitors, Chemical Biology & Drug Design, 2024, 103(1), e14372. Doi: 10.1111/cbdd.14372. |
1747-0285 |
3.20 |
19.6 |
|
|
30 |
Tantra T, Singh Y, Patekar R, Kulkarni S, Kumar P, Thareja S, Phosphate prodrugs: An approach to improve bioavailability of clinically approved drugs, Current Medicinal Chemistry, 2024, 31(3), 336-357. Doi: 10.2174/0929867330666230209094738 |
1875-533X |
3.50 |
8.4 |
|
|
31 |
Backer N, Kumar A, Singh AK, Singh H, Narasimhan B, Kumar P, Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer, Drug Discovery Today, 2024, 29(1):103853. Doi: 10.1016/j.drudis.2023.103853. |
1359-6446 |
6.50 |
23.1 |
|
|
32 |
Yadav JP, Singh AK, Grishina M, Pathak P, Verma A, Kumar V, Kumar P, Patel DK. Insights into the mechanisms of diabetic wounds: Pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies, Inflammopharmacology, 2024, 32(1):149-228. Doi: 10.1007/s10787-023-01407-6. |
1568-5608 |
4.60 |
9.9 |
|
33 |
Singh H, Singh AK, Kumar A, Kumar P, Patents on PARP-1 inhibitors for the management of cancer from 2017-2023, Recent Patents on Anti-Cancer, Drug Discovery, 2024, doi: 10.2174/0115748928315021240603073902. |
2212-3970 |
2.50 |
19.6 |
|
34 |
Sharma A, Kumar A, Singh AK, Singh H, Narasimhan B, Kumar JK, Kumar P, Ethnomedicinal uses, phytochemistry, pharmacology, and toxicology of Ruellia tuberosa L.: A review, Chemistry & Biodiversity, 2024, 21(8):e202400292. doi: 10.1002/cbdv.202400292 |
1612-1880 |
2.30 |
19.6 |
|
35 |
Yadav JP, Verma A, Pathak P, Dwivedi A.R., Singh AK, Kumar P, Khalilullah H, Jaremko M, Emwas AH, Patel DK. Phytoconstituents as Modulators of NF-κB Signalling: Investigating Therapeutic Potential for Diabetic Wound Healing. Biomedicine & Pharmacotherapy, 2024, 177:117058. doi: 10.1016/j.biopha.2024.117058. |
0753-3322
|
6.90 |
9.9 |
|
36 |
Arora M, Singh AK, Kumar A, Singh H, Pathak P, Grishina M, Yadav JP, Verma A, Kumar P, Semisynthetic Phytochemicals in Cancer Treatment: A Medicinal Chemistry Perspective, RSC Medicinal Chemistry, 2024, in press, doi: 10.1039/D4MD00317A |
2632-8682 |
4.10 |
19.6 |
|
37 |
Kumar A, Singh AK, Chaudhary RP, Sharma A, Yadav JP, Pathak P, Grishna M, Pathak K, Kumar P. Unraveling the Multifaceted Role of Nano-emulsions as Drug Delivery System for the Management of Cancer. Journal of Drug Delivery Science and Technology, 2024, doi:10.1016/j.jddst.2024.106056 |
2588-8943 |
4.50 |
19.6 |
|
38 |
Singh AK, Kumar A, and Kumar P. Refinement of MEK Inhibitors. Future Medicinal Chemistry, 2025, in press. |
1756-8927 |
3.20 |
19.6 |
|
39 |
Prajapati V, Singh A.K., Kumar A, Singh H, Pathak P, Grishina M, Kumar V, Khalilullah H, Verma A, Kumar P. Structural Insights, Regulation, Recent Advances on RAS Inhibitors in MAPK Signaling Cascade: A Medicinal Chemistry Perspective. RSC Medicinal Chemistry, 2025, in press |
2632-8682 |
4.10 |
19.6 |
National
|
S. No. |
Publication Details |
ISSN NO. |
Journal Impact factor |
API |
|
1 |
Meeta, Kumar P, Narasimhan B, Synthesis, antimicrobial evaluation and QSAR studies of p-amino benzoic acid derivatives, Journal of Pharmaceutical Technology Research and Management 2014, 2(1), 339-356. Doi: 10.15415/jptrm.2014.21007 |
2123-2225 |
-- |
2.4 |
Book Chapters Published (API Score = 100)
|
S. No. |
Publication Details |
ISBN No. |
|
1 |
Sapra A, Kakkar S, Kumar P, Narasimhan B, “An overview of anticancer potential of pyrimidine derivatives” in: Narasimhan B. (Ed), Biological profile of 5/6-membered heterocycles in the new millennium, Lambert Academic Publishing, Germany, 2013, 1-26. |
978-3-659-33078-0 |
|
2 |
Richa, Kumar P, Narasimhan B, “An overview of biological activities of thiazole derivatives” in: Narasimhan B. (Ed), Biological profile of 5/6-membered heterocycles in the new millennium, Lambert Academic Publishing, Germany, 2013, p. no. 27-58. |
|
3 |
Meeta, Kumar P, Narasimhan B, “An overview of biological activities of pyrazole derivatives” in: Narasimhan B. (Ed), Biological profile of 5/6-membered heterocycles in the new millennium, Lambert Academic Publishing, Germany, 2013, p. no. 59-94. |
|
|
4 |
Tahlan S, Kumar P, Narasimhan B, “An overview of biological activities of 1,2,4-triazole derivatives” in: Narasimhan B. (Ed), Biological profile of 5/6-membered heterocycles in the new millennium, Lambert Academic Publishing, Germany, 2013, p. no. 95-128. |
|
|
5 |
Punia P, Khatkar A, Kumar P, Narasimhan B, “An overview of biological activities of antipyrine derivatives” in: Narasimhan B. (Ed), Biological profile of 5/6-membered heterocycles in the new millennium, Lambert Academic Publishing, Germany, 2013, p. no. 129-156. |
|
|
6 |
Kumar S, Kumar P, Marwaha RK, Narasimhan B, “A comprehensive review on biological activities of gallic acid derivatives” in: Narasimhan B. (Ed), Medicinal chemistry of heterocyclic/natural compounds, Lambert Academic Publishing, Germany, 2013, 88-103. |
978-3-659-37949-9
|
|
7 |
Saini M, Kumar P, Kumar M, Narasimhan B, “A comprehensive review on biological activities of thiophene derivatives” in: Narasimhan B. (Ed), Medicinal chemistry of heterocyclic/natural compounds, Lambert Academic Publishing, Germany, 2013, 104-139. |
|
|
8 |
Saini T, Kumar P, Narasimhan B, “Biological activities of pyrazole derivatives in the new millennium” in: Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 1-33. |
978-3-659-57284-5 |
|
9 |
Bharti K, Kumar P, Kakkar S, Narasimhan B, “Biological activities of phenothiazine derivatives in the new millennium” Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 34-64. |
|
|
10 |
Rani A, Kumar M, Kumar S, Kumar P, Narasimhan B, “Biological activities of isoxazole derivatives in the new millennium” Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 65-96. |
|
|
11 |
Chugh M, Kumar P, Kumar M, Narasimhan B, “Biological activities of benzodiazepine derivatives in the new millennium” Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 97-120. |
|
|
12 |
Ritika, Marwaha RK, Kumar S, Kumar P, Narasimhan B, “Biological activities of indole derivatives in the new millennium” Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 121-140. |
|
|
13 |
Sharma D, Kumar P, Narasimhan B, “Biological activities of quinoline derivatives in the new millennium” Narasimhan B. (Ed), 21st Century: The era of heterocyclic compounds in medicinal Chemistry, Lambert Academic Publishing, Germany, 2014, p. no. 141-175. |
|
|
14 |
Singh AK, Das A, Kumar P, Nanobiosensors and Their Applications in the book Nanotechnology: Principles and Applications, Jenny Stanford Publishing Pte. Ltd., 2020, p. no. 249-288. |
9789814877435 |
|
15 |
Kumar P, Kumar R, Kumar R, Introduction in the book Fused Pyrimidine-Based Drug Discovery, Heterocyclic Drug Discovery Series, Elsevier, 2022, 1-11. |
978-0-443-18616-5 |
|
16 |
Sindhu RK,Yadav, SK; Kaur A, Kumar M, Kumar, P, X-Ray Fluorescence: Current Trends and Future Scope, in the book Fluorescence in Biological Sciences: Principles, Instrumentation, and Applications, Wiley, 2022, 623 – 646; doi: 10.1002/9781119645719.ch39 |
9781119645719 |
|
17 |
Kumar A, Singh AK, Vijayan V, Singh H, Verma A, Kumar P, Dihydropyrimidinones Scaffold and potential therapeutic targets, in the book Dihydropyrimidinones as Potent Anticancer Agents, Elsevier, 2023, 67-101. |
9780443190940 |
|
18 |
Singh AK, Singh H, Sonawane P, Kumar A, Verma A, Kumar P, Applications of dihydropyrimidinone derivatives on blood cancer and colon cancer, in the book Dihydropyrimidinones as Potent Anticancer Agents, Elsevier, 2023, 173-198. |
|
|
19 |
Kumar A, Agrawal M, Singh AK, Singh H, Kumar P, Microplastics Contamination in Marine System, in the book Microplastics: Origins, Risks, and Mitigation, Elsevier, 2024. |
9780443298059 |
|
20 |
Kumar D, Singh AK, Kumar A, Singh H, Yadav JP, Kumar P, Bioactive-Based Nanocarriers for Diabetes in the book Bioactive-Based Nanotherapeutics, John Wiley & Sons, Limited, 2024. |
9781394287314 |
RESEARCH GUIDANCE (Ph.D.) – API = 15
|
S. No. |
Name |
Regn no. |
Title |
Role |
Status |
|
1 |
Sahil Arora |
19phdphm01 |
Synthesis and anticancer assessment of indole and thienopyrimidine based analogues |
Co-supervisor |
Submitted |
|
2 |
Adarsh Kumar |
21phdphm01 |
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidine derivatives as anticancer agents |
Supervisor |
Awarded |
|
3 |
Ankit Kumar Singh |
21phdphm02 |
Design, synthesis and biological evaluation of pyrimidine-sulfonamide hybrids as anticancer agents |
Pre-submission seminar done |
|
|
4 |
Harshwardhan Singh |
21phdphm08 |
Synthesis and biological evaluation of PARP1 inhibitors as anticancer agents |
On-going
|
|
|
5 |
Vineet Prajapati |
24phdphm03 |
|
||
|
6 |
Amandeep Singh Kalsi |
24phdphm06 |
|
RESEARCH GUIDANCE (M. Pharm. THESES SUPERVISED) [API = 84]
|
S. No. |
Name of student |
Regn. No. |
Title of thesis |
Session |
|
1 |
Praveen Chauhan |
11-DVI-57 |
Development and evaluation of oral fast dissolving tablets of lornoxicam using super disintegrants – A comparative study |
2012-13 |
|
2 |
Vishal Dubey |
11-DVI-65 |
Formulation and evaluation of oral dissolving films of Lisinopril |
|
|
3 |
Rohit Kumar |
15mpharm02 |
Synthesis and in silico studies of pyrazoline containing quinoline derivatives as PI3K inhibitors |
2016-17 |
|
4 |
Rishabh Bhatia |
15mpharm06 |
Design, synthesis and in silico investigation of heterocyclic derivatives as putative anti-cancer agents |
|
|
5 |
Sahil Arora |
16mpharm07 |
Synthesis and in vitro biochemical screening of arylidene derivatives of 1,3 cyclohexanedione as Xanthine oxidase inhibitors |
2017-18 |
|
6 |
Diksha Choudhary |
16mpharm11 |
Synthesis and in silico studies of pyrazoline containing quinoline derivatives as anti-HIV agents |
|
|
7 |
Arvind Kumar |
16mpharm14 |
Synthesis and In Silico Studies of Pyrazoline containing Naphthalene Derivatives as PI3K Inhibitors |
|
|
8 |
Sonia Verma |
16mpharm16 |
Synthesis and in silico studies of quinazolinone derivatives as PARP-1 inhibitors |
|
|
9 |
Nivedita Bhardwaj |
17mpharm12 |
Synthesis and in silico studies of quinoline bridged pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
2018-19 |
|
10 |
Maneesh Gularia |
17mpharm19 |
Design and synthesis of quinazolinone derivatives as PARP-1 inhibitors |
|
|
11 |
Akashdeep Singh Pathania |
17mpharm22 |
Synthesis and in silico studies of thiazolidinone derivatives as PBP2a inhibitors |
|
|
12 |
Priya Kaundal |
18mpharm03 |
Extraction and isolation of phytoconstituents from dried leaves of Cymbopogon citratus and their in vitro anti-HIV evaluation |
2019-20 |
|
13 |
Udita Malik |
18mpharm09 |
Design, synthesis and in silico studies of isoxazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors |
|
|
14 |
Agnidipta Das |
18mpharm13 |
Design, synthesis and in silico studies of PARP-1 inhibitors as anti-triple negative breast cancer agents |
|
15 |
Ankit Kumar Singh |
18mpharm17 |
Design, synthesis and in silico studies of diaryl pyrimidine derivatives as HIV-1 nonnucleoside reverse transcriptase inhibitors |
|
|
16 |
Ankit |
19mpham01 |
In silico studies of dihydrofolate reductase inhibitors (DHFR) as antibacterial agents |
2020-21 |
|
17 |
Ritika Srivastava |
19mpham02 |
In silico studies of pyrazoline derivatives as PBP2a inhibitors
|
|
|
18 |
Adarsh Kumar |
19mpham09 |
Design, synthesis and in silico studies of diaryl pyrimidine derivatives as FabI inhibitors |
|
|
19 |
Anila Kumari VS |
19mpham10 |
In silico studies of isoxazole derivatives as anti-tubercular agents |
|
|
20 |
Gunjan Bisht |
19mphyto01 |
Mechanistic study of phytoconstituents of Pyracantha crenulata as antibacterial agents using in silico studies |
|
|
21 |
Manjusa Adak |
19mphyto04 |
Mechanistic study of natural products as anthelmintics based on in silico methods |
|
|
22 |
Priyanka Rawat |
19mphyto07 |
Extraction, phytochemical screening and in silico studies of phytoconstituents of Cassia tora roots for their antifungal activity |
|
|
23 |
Angre Tanuja Dharamraj |
20mpham01 |
Design, synthesis and in silico studies of quinazolinone derivatives as PARP-1 inhibitors |
2021-22 |
|
24 |
Kuber Kumar Bhagat |
20mpham06 |
Design, synthesis and in silico studies of pyrimidine derivatives as DHFR inhibitors |
|
|
25 |
Megha Yadav |
20mpham08 |
Design, synthesis and in silico studies of pyrazole derivatives as BRAF inhibitors |
|
|
26 |
Rasti Sahu |
20mpham14 |
Design, synthesis and in silico studies of benzimidazole derivatives as MEK inhibitors |
|
|
27 |
Soni Dhaulakhandi |
20mphyto01 |
Extraction, phytochemical screening and biological evaluation of Rubus ellipticus root extracts |
|
|
28 |
Bondalakunta Saieswar |
20mphyto03 |
Extraction, phytochemical screening and biological activities of Aglaia elaeagnoidea leaves’ extracts |
|
|
29 |
Shikha Agrawal |
20mphyto01 |
Extraction, phytochemical profiling and biological evaluation of Prunus cerasoides leaf extracts |
|
|
30 |
Akanksha Sharma |
20mphyto09 |
Extraction, phytochemical analysis and in vitro biological evaluation of leaves’ extracts of Ruellia tuberosa L. |
|
|
31 |
Harshali Paliwal |
21mpharm04 |
Design, synthesis and in silico studies of pyrido[2,3-d]pyrimidine derivatives as thymidylate synthase inhibitors |
2022-23 |
|
32 |
Teja Ram |
21mpharm07 |
One pot synthesis, in silico and biological evaluation of diaryl-benzimidazole derivatives as MEK inhibitors |
|
|
33 |
Pankaj Sonawane |
21mpharm11 |
Design, synthesis and in silico studies of chalcone-sulfonamide derivatives as a BRAF inhibitors |
|
|
34 |
Deepak Kumar |
21mphyto01 |
Extraction, phytochemical screening and anthelmintic evaluation of Rubus ellipticus leaves extracts |
|
|
35 |
Veena Vijayan |
21mphyto08 |
Extraction, phytochemical profiling and antibacterial evaluation of Bauhinia acuminata leaves extracts |
|
|
36 |
Guguloth Jashwanth Naik |
21mphyto09 |
Extraction, isolation of curcumin from Curcuma longa and in silico studies of curcumin |
|
|
37 |
Mallika Agrawal |
22mpharm02 |
Design, synthesis and antibacterial activity of thiophene based pyrido[2,3-d]pyrimidines targeting UTI causing bacteria |
2023-24 |
|
38 |
Vimlendu Kumar Sah |
22mpharm10 |
Design and synthesis of pyrimidine sulphonamide hybrids as potential ERK inhibitors |
|
|
39 |
Vineet Prajapati |
22mpharm11 |
Design and synthesis of pyrimidine sulfonamide derivatives as potential KRAS inhibitors |
|
|
40 |
Meghna Arora |
22mphyto01 |
Extraction, synthesis of silver and gold nanoparticles using stem bark extract of Jatropha Integerrima Jacq. and their biological evaluation |
|
|
41 |
Arvind Sharma |
22mphyto08 |
Extraction, isolation, phytochemical screening, and synthesis of silver nanoparticles from methanolic extract of Cyclea peltata: A comparative antibacterial activity of extracts and silver nanoparticles |
|
|
42 |
Ravi Prakash Chaudhary |
22mphyto17 |
Extraction, phytochemical screening, synthesis of silver nanoparticles and antibacterial evaluation of Crinum asiaticum leaves extracts: A comparative study |
RESEARCH GUIDANCE (M. Sc. DISSERTATIONS SUPERVISED)
|
S. No. |
Name of student |
Regn No. |
Title of thesis |
Session |
|
1 |
Prateek Singh Bora |
15mscchs01 |
Hansch analysis for the antifungal activity of indole derivatives |
2016-17 |
|
2 |
Mir Sahidul Ali |
15mscchs09 |
Synthesis and in silico studies of quinoline derivatives against PBP2a |
|
|
3 |
Mridul |
15mscchs13 |
Hansch analysis for the anti-bacterial activity of indole derivatives |
|
|
4 |
Kanika Garg
|
16mscchs02 |
Design and synthesis of pyridine derivatives as pbp2a inhibitors |
2017-18 |
|
5 |
Pooja Kumari |
16mscchs09 |
Design and in silico studies of CCR5 receptor antagonists as anti-HIV agents |
|
|
6 |
Uttam Kumar Mishra |
16mscchs17 |
Design and in silico studies of azole derivatives as Mycobacterium tuberculosis CYP51 inhibitors |
|
|
7 |
Ann Kurian |
17mscchs05 |
Design and in silico studies of dihydrofolate reductase (DHFR) inhibitors as antibacterial agents |
2018-19 |
|
8 |
Sanni Dev |
17mscchs08 |
In silico studies of HIV Protease Inhibitors as anti-HIV agents |
|
|
9 |
Aratrika Halder |
17mscchs09 |
Design and in silico studies of DNA gyrase inhibitors |
|
|
10 |
Rahul Kumar Chauhan |
18mscchs08 |
Quinazoline derivative as PI3K inhibitors |
2019-20 |
|
11 |
Ashrulochan Sahoo |
18mscchs14 |
Design and in silico studies of pyrimidine derivatives as HIV Reverse Transcriptase inhibitors |
|
|
12 |
Priya Jindal |
18mscchs17 |
Design and in silico studies of purine derivatives as HIV Reverse Transcriptase inhibitors |
|
|
13 |
B Sanjeev |
19mscchs10 |
Thymidylate synthase inhibitors as antimicrobial agents |
2020-21 |
|
14 |
Naincy Pal |
19mscchs14 |
Molecular docking studies of DNA gyrase inhibitors as anti-VRE agents |
|
|
15 |
Munavvir KP |
19mscchs15 |
Molecular docking studies of DNA gyrase inhibitors as anti-multidrug resistant Pseudomonas aeruginosa agents |
|
|
16 |
Sagar Sinha |
19mscchs16 |
α-Glucosidase as a molecular targets for anti-diabetic agents |
|
|
17 |
Aditya Raj |
20mscchs01 |
Molecular docking studies of quinazoline derivatives as PI3Kα inhibitors |
2021-22 |
|
18 |
Irine Pauly |
20mscchs08 |
Current insights and molecular docking studies of FDA approved or drugs under clinical trial as RdRp inhibitors for COVID-19 treatment |
|
|
19 |
Niyatha Lohithakshan K |
20mscchs11 |
In silico studies of US-FDA approved drugs or drugs under clinical trial which violate Lipinski’s rule of 5 |
|
|
20 |
Vaishali |
20mscchs18 |
In silico studies of 1,2,3- trizoles as PARP-1 inhibitors |
|
|
21 |
Priti |
20mscchs022 |
In silico studies of imidazole derivatives as anti-MRSA agents |
|
|
22 |
Naveen Kumar |
21mscchs11 |
In silico studies of pyrimidine derivatives as thymidylate synthase inhibitors |
2022-23 |
|
23 |
Nabeel Backer |
21mscchs11 |
Design, synthesis, and in silico studies of pyrido[2,3-d]pyrimidine derivatives as anti-colorectal cancer agents targeting duTPase |
|
|
24 |
P. Sreelakshmi |
21mscchs21 |
Design, virtual screening, molecular docking, in silico ADME and cytotoxicity studies of 1,3,5-triazine containing heterocyclic scaffolds as selective BRAF monomeric, homo and heterodimeric inhibitors |
|
25 |
Shibangi Bhattacharjee |
22mscchs02 |
Synthesis and in silico studies of biphenyl based pyrido[2,3-d]pyrimidine derivatives as antibacterial agents |
2023-24 |
|
26 |
Pankaj Mishra |
22mscchs11 |
In silico studies of reported mek inhibitors to identify selectivity against MEK1 and MEK2 proteins |
|
|
27 |
Mamatha Saladi |
22mscchs14 |
Design, synthesis and in silico studies of naphthalene based pyrido-pyrimidine derivatives as antibacterial agents |
|
|
28 |
Suman Kumar |
22mscchs27 |
An in silico approach to identify selectivity of reported BRAF inhibitors against BRAF monomeric, homodimeric and heterodimeric proteins |
conferences/ SeMINARS: Poster/Oral presentations
|
S. No. |
Details of presentation |
|
1 |
Pradeep Kumar, Deepika Sharma, Narasimhan B, Adverse Drug Reactions, 7th Annual conference of Society of Pharmacovigilance, 23-25 Nov. 2007, National Institute of Medical Sciences Medical College and Hospital, Jaipur. |
|
2 |
Pradeep Kumar, Deepika Sharma, Narasimhan B, QSAR studies by Free Wilson analysis, Abstract No.RTPER-103, P-78, National Seminar on Recent Trends in Pharmaceutical Education and Research, 29-30 Sept. 2007, Rajendra Institute of Technology and Sciences, Sirsa. |
|
3 |
Pradeep Kumar, Deepika Sharma, Narasimhan B, Antimicrobial substituted benzoic acid linked substituted benzylidene hydrazides, Abstract No-B-220, P-202, Proceedings of 59th Indian Pharmaceutical Congress, 20-23 Dec. 2007, BHU, Varanasi. |
|
4 |
Pradeep Kumar, Balasubramanian Narasimhan, Synthesis, antimicrobial and anticancer evaluation of 3/4-bromo-N'-(substituted benzylidene/ furan-2-ylmethylene/ 5-oxopentylidene/ 3-phenylallylidene) benzohydrazides, IPGA national convention-17- 18 November 2012, held at Kurukshetra University, Kurukshetra [Abstract no. IPGANC-144]. |
|
5 |
Pradeep Kumar, Balasubramanian Narasimhan, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 2/3-bromo-N'-(substituted benzylidene/3-phenylallylidene) benzohydrazides, 18th Annual Convention of Society of Pharmacognosy on “Promotion and Globalisation of Indian Herbal Products- Perspectives and Prospects” held at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak on February 21-22, 2014 (Abstrat no. ISPPH-235). |
|
6 |
Pradeep Kumar, Balasubramanian Narasimhan, Hansch analysis of substituted benzoic acid benzylidene/furan-2-yl-methylene hydrazides as antimicrobial agents, UGC Sponsored National Seminar on Recent Trends and Innovations in Pharmaceutical Research, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak held on 8th March, 2014. |
|
7 |
Pradeep Kumar, Balasubramanian Narasimhan, Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides, International Conference on Drug Resistance, Development, Pharmaceutical Technology and Outcomes, College of Pharmacy, Chitkara University, Rajpura, Punjab, held on April 11-12, 2014. |
|
8 |
Pradeep Kumar, Balasubramanian Narasimhan, Ruma Saharan, Hansch analysis of anti-inflammatory and analgesic activities of substituted 1-alkyl/aryl-3-ethoxy carbonyl-5-hydroxy-2-methyl indoles, 1st Annual Conference of Association of Pharmaceutical Teachers of India, Haryana State Branch, held at Kurukshetra university, Kurukshetra on August 22-23, 2014 (Abstrat no. PCHEM 15) |
|
9 |
Pradeep Kumar, Balasubramanian Narasimhan, Triple-negative Breast Cancer, 2nd Annual Conference of Association of Pharmaceutical Teachers of India (APTI) - Haryana State Branch, held on 24th and 25th October, 2015 at Department of Pharmaceutical Sciences, Maharshi Dayanand University Rohtak, Haryana (Abstrat no. APTI-MDU/102) |
|
10 |
Pradeep Kumar, Mridul, Balasubramanian Narasimhan, Hansch analysis for the antibacterial activity of indole derivatives, 69th Indian Pharmaceutical Congress held at Chitkara University, Banur on December 22-24, 2017 (Poster No:B-69). |
|
Oral Presentations |
|
|
1 |
Pradeep Kumar, Balasubramanian Narasimhan, Synthesis, antimicrobial, antiviral evaluation and QSAR studies of substituted benzoic acid {4-[(substituted imino/phenylimino/naphthalen-1-ylimino/benzylimino)-methyl]-benzylidene}-hydrazides, 6th National Conference On Thermodynamics of Chemical And Biological Systems (NCTCBS-2011, OP-67), held on 02-04-11, Department of Chemistry, Maharshi Dayanand University, Rohtak. |
|
2 |
Pradeep Kumar, Jitender Mor, Rajinder Mannn and Balasubramanian Narasimhan, Fixed-dose combinations: Merits and Demerits, International conference on “Global trends in pharmaceutical & clinical practices” organized by College of Pharmacy, Teerthanker Mahaveer University, Moradabad, U.P. on February 06-07, 2015. |
|
3 |
Pradeep Kumar, Doping in sports, Regional Seminar on “Socio-Legal and other Challenges for the Prevention of Drug Abuse in India: Existing Approaches and Agenda of Reform”, Held at Central University of Punjab, Bathinda on August 24-25, 2017. |
Other Poster presentations
- Deepika Sharma, Pradeep Kumar, Narasimhan B, Importance of outlier’s detection and their removal in drug discovery by QSAR studies, Abstract No. RTPER-041, P-38, National Seminar on Recent Trends in Pharmaceutical Education and Research, 29-30 Sept. 2007, Rajendra Institute of Technology and Sciences, Sirsa.
- Deepika Sharma, Pradeep Kumar, Tushar Dhamija, Munish Ahuja, Narasimhan B, Off label Drugs, Abstract No. 104, 7th Annual conference of Society of Pharmacovigilance, 23-25 Nov. 2007, National Institute of Medical Sciences Medical college and Hospital, Jaipur.
- Deepika Sharma, Pradeep Kumar, Narasimhan B, Preparation and antimicrobial evaluation of 2-(substituted phenyl)-1-H-benzimidazoles Abstract No-B-202, P-198, Proceedings of 59th Indian Pharmaceutical Congress, 20-23 Dec. 2007, Varanasi.
- Kuldeep Mahiwal, Pradeep Kumar and Balasubramanian Narasimhan, Synthesis, antimicrobial and QSAR studies of 2-amino Benzoic Acid, AICTE Sponsored National Seminar on Recent Trends in Pharmaceutical Research, August 7-8, 2010, p. 26 [Abstract No. PC-110].
- Pooja, Pradeep Kumar, Mahesh Kumar, Balasubramanian Narasimhan, 4-Nitro benzoic acid derivatives: Synthesis, antimicrobial evaluation and Quantitative Structure Activity Relationship studies, AICTE sponsored National Seminar on Recent Trends in Pharmaceutical Research, M.M.College of Pharmacy,Mullana-133207, AMBALA, August 7-8, 2010, p. 30 [Abstract No. PC-123].
- Sneh Lata, Pradeep Kumar and Balasubramanian Narasimhan, Correlation of antimicrobial activities of 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulphonic acids using Hansch analysis, AICTE Sponsored National Seminar on Recent Trends in Pharmaceutical Research, August 7-8, 2010, p. 34 [Abstract No. PC-134].
- Mahak Saini, Pradeep Kumar, Mahesh Kumar, Balasubramanian Narasimhan, Synthesis, in vitro antimicrobial and anticancer evaluation and QSAR studies of N’-(substituted)-4-(butan-2-ylideneamino) benzohydrazides, IPGA national convention-17- 18 November 2012, held at Kurukshetra university, Kurukshetra [Abstract no. IPGANC-143].
- Sanjiv Kumar, Pradeep Kumar, Rakesh Kumar Marwaha, Balasubramanian Narasimhan, Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 3,4,5-trihydroxy benzoic acid derivatives, IPGA national convention-17- 18 November 2012, Kurukshetra university, Kurukshetra [Abstract no. IPGANC-145].
- Sneh Lata, Shinky Mehta, Pradeep Kumar, Rakesh Kumar Marwaha, Balasubramanian Narasimhan, Synthesis, antimicrobial and anticancer evaluation of n-[2-(4-chloro-phenyl)-4-oxo-4h-quinazolin-3-yl]-2-(substitutedphenylamino)-acetamide derivatives, IPGA national convention-17- 18 November 2012, held at Kurukshetra university, Kurukshetra [Abstract no. IPGANC-146].
- Sumit Tahlan, Pradeep Kumar, Balasubramanian Narasimhan, Synthesis, antimicrobial and anticancer evaluation of 1,2,4-triazole derivatives, IPGA national convention-17- 18 November 2012, held at Kurukshetra university, Kurukshetra [Abstract no. IPGANC-146].
- Jitender Mor, Pradeep Kumar, Rajinder Mann, Ram Kumar Roy, Liposomes as drug delivery systems, UGC Sponsored National Seminar on Recent Trends and Innovations in Pharmaceutical Research, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak held on 8th March, 2014.
- Rajinder Mann, Pradeep Kumar, Jitender Mor, Ram Kumar Roy, Pharmacognostical and physico-chemical evaluation of the stem of Solena amplexicaulis (lam.) Gandhi, 18th Annual Convention of Society of Pharmacognosy on “Promotion and Globalisation of Indian Herbal Products- Perspectives and Prospects” held at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak on February 21-22, 2014 (Abstrat no. ISPPH-233).
- Teena Saini, Pradeep Kumar, Saloni Kakkar, Balasubrmanian Narasimhan, Synthesis, antimicrobial and anticancer evaluation of N-((3-(4-substituted phenyl)-1-phenyl-1H-pyrazol-4-yl) methylene)-substituted benzenamines, 18th Annual Convention of Society of Pharmacognosy on “Promotion and Globalisation of Indian Herbal Products- Perspectives and Prospects” held at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak on February 21-22, 2014 (Abstrat no. ISPPH-233).
- Rajinder Mann, Pradeep Kumar, Jitender Mor, Ram Kumar Roy, Pharmacognostical standardization of the roots of Solena amplexicaulis (lam.) Gandhi, UGC Sponsored National Seminar on Recent Trends and Innovations in Pharmaceutical Research, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak held on 8th March, 2014.
- Ram Kumar Roy, Pradeep Kumar and Prince Prasant Sharma, Conversion of isolated betulin betulenic acid to via Jone’s oxidation, International Conference on Drug Resistance, Development, Pharmaceutical Technology and Outcomes, College of Pharmacy, Chitkara University, Rajpura, Punjab, held on April 11-12, 2014.
- Jitender Mor, Pradeep Kumar, Rajinder Mann, Ram Kumar Roy, Recent advances in colon targeted drug delivery systems, International Conference on Drug Resistance, Development, Pharmaceutical Technology and Outcomes, College of Pharmacy, Chitkara University, Rajpura, Punjab, held on April 11-12, 2014.
- Rajinder Mann, Pradeep Kumar, Jitender Mor, Ram Kumar Roy, Pharmacognostical and physico-chemical evaluation of the roots of Cryptolepis dubia (Burm.f.) M.r. Almedia, International Conference on Drug Resistance, Development, Pharmaceutical Technology and Outcomes, College of Pharmacy, Chitkara University, Rajpura, Punjab, held on April 11-12, 2014.
Attended
- 12th Annual APTI National Convention Reorienting Pharmaceutical Education for Future Challenges, 25th -27th Oct, 2007 at UIPS, Panjab University, Chandigarh.
- National Seminar on Advances and Regulatory Aspects for Pharmaceutical and Herbal Drugs, October 31, 2009, Chitkara College of Pharmacy, Punjab, India.
- National seminar on “Challenges in Combating Diseases: Cause to Cure”, March 23, 2012 held at Department of Zoology, Maharshi Dayanand University, Rohtak.
- “Continuing Pharmacy Education” program organized by Haryana State Pharmacy Council, held at Rohtak on October 14, 2012.
- 65th Indian Pharmaceutical Congress held at Amity University, Noida on December 20-22, 2013.
- Attended Acquaintance Program of Inter University Accelerator Centre, New Delhi at Central University of Punjab, Bathinda organized on 4th April, 2016.
- 3rd Annual Conference of APTI-Haryana State Branch, organized by Jan Nayak Ch. Devi Lal College of Pharmacy, Sirsa, Haryana, Held on November 11-12, 2016
Training Programs/ Workshops
- Two months industrial training on “Formulation and quality controle of parenteral small volume (injectable and ophthalamic)” at Regain Laboratories, Hisar, Haryana (1st June 2005 to 31st July, 2005).
- ISTE sponsored Short Term Training Programme on “Recent Advances in Drug Development: Role of Novel Drug Delivery System”, 2nd -6th Feb., 2009 held at PDM College of Pharmacy, Bahadurgarh, Haryana.
- Career Counselling and Placement Cell Sponsored Two Day Workshop on Personality Development, Communication skills and Resume writing, held at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak March 22 and 23, 2013.
- DSW sponsored one-day workshop on “Instrumental Methods in Pharmaceutical Resrearch” held at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak on 28th November, 2013.
- One-day Workshop on “Handling of Sophisticated Analytical Instruments” held at Jan Nayak Chaudhary Devi Lal College of Pharmacy, Sirsa, Haryana on July 19, 20014.
- Attended IPR clinic: A workshop on “Patent, Copyright drafting and Design Registration” at College of Pharmacy, Chitkara University, Rajpura, Punjab, held on January 16, 2015.
- UGC sponsored Orientation Program organized by HRDC, GJUS&T, Hisar, Haryana from May 12, 2016 to June 8, 2106.
- Attended one-day workshop on “Prime Minister’s Fellowship for Doctoral Research” held at at Central University of Punjab, Bathinda on May 3rd, 2017.
- 2 Days Training Programme for Nominees of CPCSEA to be held at Ganga Auditorium, Indira Paryavaran Bhawan, New Delhi on 18th and 19th September, 2018
- PCI sponsored Continuing Education program organized by MRSPTU Bathinda on September 27-29, 2018.
- PMMMNMTT (MHRD sponsored) National workshop on Curriculum Design and Development, organized by School of Education, Central University of Punjab from 28-01-2019 to 06-02-19.
- AICTE Training and Learning (ATAL) Academy FDP on "Artificial Intelligence" from 09-12-2019 to 13-12- 2019 at Central University of Punjab.
- PMMMNMTT (MHRD sponsored) Two Weeks Faculty Development Programme on "MANAGING ONLINE CLASSES and CO-CREATING MOOCS" organized by Ramanujan College, New Delhi from April 20 - May 06, 2020.
- Introduction to Computational Drug Design (Theory-Demlo-Hands-on), co-organized by Schrodinger and Pharmacy Council of India between 21st September to 23rd October, 2020.
- AICTE Sponsored One Week (24- 05-2021 to 29-05-2021) Online National Level Teacher’s Training Programme On “NBA Accreditation and Processes” organised by GVM Institute Of Technology & Management (For Girls), Sonepat.
Organized a three day workshop on “Drug Design, Molecular Docking, Virtual Screening and Pharmacoinformatics” 26 th -28 th November, 2015 at Central University of Punjab, Bathinda
Organized a three day advanced workshop on “Molecular Docking, virtual screening and computational biology” 15 th -17 th November, 2017 at Central University of Punjab, Bathinda
Organized Workshop and Hands-on Training on “High-Performance Thin Layer Chromatography (HPTLC)” December 5-6, 2019 at Central University of Punjab, Bathinda
Organized Two days workshop on “Advanced Computer-Aided Drug Design and Computational Biology” December 18-19, 2019 at Central University of Punjab, Bathinda
A two-day cloud-based hands-on workshop on ‘Computational Structure-based Screening and Explicit Molecular Dynamics’ May 11-12, 2021
Advanced Session on Patenting Strategies and Patent search exercise for inventions in Pharmaceutical Sciences” organized by Institution's Innovation Council (IIC), Intellectual Property Rights Cell (IPR Cell), Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab & Innovation-Technology Transfer Office (i-TTO), held on 1st December, 2021
PEER RECOGNITION
- Member, Editorial Board, Current Traditional Medicine (Bentham Science Publisher)
Reviewer of various international journals like:
- International Journal of Biological Macromolecules (Elsevier).
- Medicinal Chemistry Research & Chemistry Central Journal (Springer).
- Anti-Cancer Agents in Medicinal Chemistry (Bentham Science Publishers).
- Drug Research (Thieme).
- Journal of Applied Pharmaceutical Science (Open Science Publishers)
1 12-09-14 Green Chemistry Two Days Faculty Development Programme in collaboration with Indian Pharmacological Society on Emerging Trends in Pharmaceutical Practices, held at Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, U.P. on 12th to 13th September, 2014. 03
2. 14-04-18 E-Poster Session Evaluator “PHYTOCON-2018” on “Commercializaton of Medicinal Plant Products: Lab Techniques to Trade” organized by School of Pharmaceutical Sciences, Lovely Professional University 03
3. 22-09-23 2D QSAR in drug Design One day workshop on “In silico Drug Design and Synthesis” organized by Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda 02
4. 21-03-24 Oral presentation evaluation International conference on "Emerging goal and Challenges in Pharmaceutical Technology and Allied Sciences (ICPTA-2024), Guru Jambheshwar University of Sciences and Technology, Hisar 03
5. 12-11-24 Resource Person (Evaluator) International Conference, Pharmacy Horizons: Pioneering Trends in Pharmaceutical Research and Development, RIMT University, Mandi Gobindgarh, Punjab 03
6. 28-11-24 Resource Person (Evaluator) International Pharmacology Conference (IPC) & 54th Annual Conference of Indian Pharmacological Society 2024, held at AIIMS, New Delhi on November 28-30, 2024 03
PATENT FILED
PATENT PUBLISHED
Citations (Google Scholar) - 2942
|
h-index - 27 |
i10- index -55